Regeneration Technologies loses half its value as it delays results
This article was originally published in Clinica
Regeneration Technologies' (RTI) shares lost more than half their value last week, reaching $4.96 before trading in the company was stopped. The drop came after the company announced that it was delaying the release of its fourth-quarter and full-year results until it finishes evaluating "certain inventory issues". Regeneration's current share price marks a new year-low and compares with a 52-week high of over $15.